Hikal Quarterly Results for Trading Insights

HIKAL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-35 Cr
QSept 2025
Quarterly Results

Hikal Quarterly Results Key Highlights

  • Revenue of ₹318 Cr in Sept 2025 (-42.3% vs Mar 2025, -29.5% vs Sept 2024)
  • Net Profit of ₹-35 Cr in Sept 2025 (-170.0% vs Mar 2025, -294.4% vs Sept 2024)
  • EBITDA of ₹7 Cr in Sept 2025 (-94.3% vs Mar 2025)
  • Operating Margin of 2.0% in Sept 2025 (-20.0pp vs Mar 2025)
  • Earnings Per Share of ₹-2.83 in Sept 2025 (-169.5% vs Mar 2025)

Hikal Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 QoQ YoY
Revenue (₹ Cr) 318 551 372 451 513 -42.3% -29.5%
Net Profit (₹ Cr) -35 50 -22 18 34 - -
EBITDA (₹ Cr) 7 122 17 73 94 - -
EPS (₹) -2.83 4.07 -1.82 1.48 2.76 - -
Operating Margin (%) 2.0% 22.0% 4.0% 16.0% 18.0% - -

Hikal Share Price Trend Around Quarterly Results

Visualize Hikal's 1-year price movement across quarterly results — ideal for logging trades in Hikal share price chart using Tickjournal. All values in ₹.

Related Pages for Hikal

Additional stock information and data for HIKAL

HIKAL PE ratio trends
HIKAL price range
Hikal share price today live chart
HIKAL price book multiple
HIKAL FII DII holdings
HIKAL fundamental worth
Hikal valuation methods
HIKAL complete financial

Profitability Ratios

Profit Margin -11.0%
EBITDA Margin 2.2%
Operating Margin 2.0%
ROE (Annual) -11.1%

Balance Sheet Highlights

Total Assets ₹2,529 Cr
Total Equity ₹1,262 Cr
Current Assets ₹995 Cr
Current Liabilities ₹477 Cr

Cash Flow Analysis

Operating Cash Flow ₹280 Cr
Investing Cash Flow ₹-137 Cr
Financing Cash Flow ₹-144 Cr
Net Cash Flow ₹0 Cr

Current Market Data

Current Price ₹215.51
Exchange NSE
Last Updated Jan 09, 2026

Revenue Trend (₹ Cr)

Sept 2024 451
Jun 2025 372
Mar 2025 551
Sept 2025 318

Net Profit Trend (₹ Cr)

Sept 2024 18
Jun 2025 -22
Mar 2025 50
Sept 2025 -35

Operating Margin Trend (%)

Sept 2024 16.0%
Jun 2025 4.0%
Mar 2025 22.0%
Sept 2025 2.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Hikal quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹417,052.40 Cr 1729.9 14,875 3,125 +10.8% - 21.0% 133.1
Divis Laboratories
Sept 2025 		₹176,337.50 Cr 6616.5 2,860 689 +7.1% - 24.1% 254.8
Torrent Pharmaceuti…
Sept 2025 		₹136,522.12 Cr 3963.4 3,219 591 +11.3% - 18.4% 226.0
Cipla
Sept 2025 		₹118,572.82 Cr 1465.7 7,716 1,353 +12.0% - 17.5% 87.6
Dr Reddys Laborator…
Sept 2025 		₹100,998.62 Cr 1210.1 9,135 1,337 +1.1% - 14.6% 74.8
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores